Cargando…

Effect of Favorable Pathologic Response After Neoadjuvant Radiation Therapy Alone in Soft-tissue Sarcoma

PURPOSE: Whether the therapeutic response of soft-tissue sarcoma to neoadjuvant treatment is predictive for clinical outcomes is unclear. Given the rarity of this disease and the confounding effects of chemotherapy, this study analyzes whether a favorable pathologic response (fPR) after neoadjuvant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palm, Russell F., Liveringhouse, Casey L., Gonzalez, Ricardo J., Bui, Marilyn M., Binitie, Odion, Yang, George Q., Naghavi, Arash O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Scientific Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723307/ https://www.ncbi.nlm.nih.gov/pubmed/36483058 http://dx.doi.org/10.1016/j.adro.2022.101086

Ejemplares similares

Synovial sarcoma of bone: Sarcoma typically of soft tissues presenting as a primary bone tumor
por: Caracciolo, Jamie T., et al.
Publicado: (2018)

Chemotherapy improves distant control in localized high-grade soft tissue sarcoma of the extremity/trunk
por: Rizk, Victoria T., et al.
Publicado: (2020)

Surgical and Pathologic Outcomes of Pancreatic Adenocarcinoma (PA) After Preoperative Ablative Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy (A-SMART)
por: Bryant, J.M., et al.
Publicado: (2022)

Neoadjuvant chemoradiation compared to neoadjuvant radiation alone and surgery alone for Stage II and III soft tissue sarcoma of the extremities
por: Curtis, Kelly K, et al.
Publicado: (2011)

Using the revised Edmonton symptom assessment scale during neoadjuvant radiotherapy for retroperitoneal sarcoma
por: Palm, Russell F., et al.
Publicado: (2020)

Neoadjuvant Chemoradiation Compared With Neoadjuvant Radiation Alone in the Management of High-Grade Soft Tissue Extremity Sarcomas
por: Hazell, Sarah Z., et al.
Publicado: (2019)

The Future of Radiation Oncology in Soft Tissue Sarcoma
por: Naghavi, Arash O., et al.
Publicado: (2018)

Recurrent Aneurysmal Bone Cyst of the Distal Fibula Treated with Denosumab and Curettage
por: Fontenot, Philip B., et al.
Publicado: (2018)

Myopericytoma/myopericytomatosis of the lower extremity in two young patients: a recently designated rare soft tissue neoplasm
por: Peters, Katherine, et al.
Publicado: (2017)

Long-Term Clinical Responses of Neoadjuvant Dendritic Cell Infusions and Radiation in Soft Tissue Sarcoma
por: Raj, Shailaja, et al.
Publicado: (2015)

Optimizing Outcomes for Patients With Soft-Tissue Sarcoma Through the Multidisciplinary Medical Oncology/Radiation/Surgical Team Approach
por: Naghavi, Arash, et al.
Publicado: (2018)

Preoperative Stereotactic Body Radiation Therapy for Soft-Tissue Sarcoma: Results of Phase 2 Study
por: Kubicek, Gregory J., et al.
Publicado: (2021)

Predictive Biomarkers of Pathological Response to Neoadjuvant Chemoradiotherapy for Locally Advanced Soft Tissue Sarcomas
por: Szumera-Ciećkiewicz, Anna, et al.
Publicado: (2023)

Orbital Alveolar Soft Part Sarcoma Misdiagnosed as Hemangioma in an Infant
por: Çakmakcı, Selma, et al.
Publicado: (2023)

Osteosarcoma in Pediatric Patients and Young Adults: A Single Institution Retrospective Review of Presentation, Therapy, and Outcome
por: Haddox, Candace L., et al.
Publicado: (2014)

Neoadjuvant Treatment Options in Soft Tissue Sarcomas
por: Spałek, Mateusz Jacek, et al.
Publicado: (2020)

Early Outcomes of Preoperative 5-Fraction Radiation Therapy for Soft Tissue Sarcoma Followed by Immediate Surgical Resection
por: Parsai, Shireen, et al.
Publicado: (2020)

Patterns of Failure in High-Grade Soft Tissue Sarcomas of the Extremities and Trunk Wall After Pre- or Postoperative Radiation Therapy
por: Roohani, Siyer, et al.
Publicado: (2023)

Neoadjuvant chemotherapy for radiation-associated soft-tissue sarcoma: A case report
por: Patel, Ronak, et al.
Publicado: (2019)

Neoadjuvant Chemoradiation Herapy for Soft Tissue Sarcomas of the Extremities
por: Aguiar, Samuel, et al.
Publicado: (2009)

Controversies and consensus of neoadjuvant chemotherapy in soft-tissue sarcomas
por: Loong, Herbert H., et al.
Publicado: (2018)

Neoadjuvant sequential chemoradiotherapy versus radiotherapy alone for treatment of high-risk extremity soft tissue sarcoma: a single-institution experience
por: Kılıç, Leyla, et al.
Publicado: (2017)

Radiation Therapy Before Repeat Wide Resection for Unplanned Surgery of Soft Tissue Sarcoma (“Oops” Operation) Results in Improved Disease-Free Survival
por: Kollender, Roni, et al.
Publicado: (2022)

Hyperprogression of Liver Metastasis With Neoadjuvant Immunotherapy for Soft Tissue Sarcoma
por: Chan, Abigail S, et al.
Publicado: (2020)

Neoadjuvant Radiotherapy-Related Wound Morbidity in Soft Tissue Sarcoma: Perspectives for Radioprotective Agents
por: Callaghan, Cameron M., et al.
Publicado: (2020)

Treatment pathway of bone sarcoma in children, adolescents, and young adults
por: Reed, Damon R., et al.
Publicado: (2017)

Impact of postoperative baseline MRI on diagnostic confidence and performance in detecting local recurrence of soft-tissue sarcoma of the limb
por: Goller, Sophia Samira, et al.
Publicado: (2023)

Trimodal Therapy Using an MR–guided Radiation Therapy Partial Bladder Tumor Boost in Muscle Invasive Bladder Cancer
por: Liveringhouse, Casey, et al.
Publicado: (2023)

Radiographic and Histologic Response to Neoadjuvant Radiotherapy in Patients With Soft Tissue Sarcoma
por: Canter, Robert J., et al.
Publicado: (2010)

Neoadjuvant radiotherapy for soft tissue sarcoma in China: a preliminary result
por: Huang, Zhen, et al.
Publicado: (2022)

Pathologic response after neoadjuvant chemotherapy predicts locoregional control in patients with triple negative breast cancer
por: Chen, Victor E., et al.
Publicado: (2017)

Updates in Pathology for Retroperitoneal Soft Tissue Sarcoma
por: Mack, Tanner, et al.
Publicado: (2022)

Intramedullary rod failure in metastatic breast cancer: Do triple negative cancer patients have more revision surgery?
por: Belzarena, Ana C., et al.
Publicado: (2021)

Genomic identification of sarcoma radiosensitivity and the clinical implications for radiation dose personalization
por: Yang, George, et al.
Publicado: (2021)

Hypofractionated Radiation Therapy for Unresectable or Metastatic Sarcoma Lesions
por: Boyce-Fappiano, David, et al.
Publicado: (2022)

PROMIS scores of patients undergoing neoadjuvant and adjuvant radiation therapy for surgically excised soft tissue sarcoma
por: Moon, T.M., et al.
Publicado: (2021)

Outcomes and computed tomography radiomic features extraction in soft tissue sarcomas treated with neoadjuvant radiation therapy
por: González-Viguera, Javier, et al.
Publicado: (2021)

Neoadjuvant Radiation Therapy with Interdigitated High-Dose LRT for Voluminous High-Grade Soft-Tissue Sarcoma
por: Hatoum, Georges F, et al.
Publicado: (2023)

Is 5 the New 25? Long-Term Oncologic Outcomes From a Phase II, Prospective, 5-Fraction Preoperative Radiation Therapy Trial in Patients With Localized Soft Tissue Sarcoma
por: Bedi, Meena, et al.
Publicado: (2022)

Myoepithelial carcinoma with RB1 mutation: remarkable chemosensitivity to carcinoma of unknown origin therapy
por: Hoggard, Timothy M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qhrddhh8t72d03agq8kssttudt